As Russia's nuclear doctrine update rattles markets, Moody's places Boeing under review and AbbVie raises neuroscience sales outlook

News that Russian President Vladimir Putin updated his country's nuclear doctrine negatively impacted risk appetite in global markets. Following this news flow regarding geopolitical developments, US stock futures and bond yields experienced declines. Similarly, impacted by the weak close on Wall Street and computer outages, European stock markets also started the day with losses.

Financial pressures are increasing for aviation and defense giant Boeing. International credit rating agency Moody's announced that it has placed all of Boeing's credit ratings on review for a possible downgrade. This development indicates that the rating agency will closely review the company's current financial situation.

On the other hand, pharmaceutical company AbbVie is drawing attention with the performance of its neuroscience unit. Company management announced that they project reaching a sales volume of 12,7 billion dollars this year in neuroscience, which has become a growth engine.

On the housing finance side, a decline was recorded in mortgage and refinancing interest rates in the US. Current data announced as of Sunday, 16 August 2026 revealed that mortgage and refinancing rates mostly materialized at lower levels compared to last week.

This content is for general information purposes and is not investment advice.